These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
792 related items for PubMed ID: 28638313
1. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs. Groth A, Wilke T, Borghs S, Gille P, Joeres L. Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313 [Abstract] [Full Text] [Related]
2. Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy. Brodie MJ. CNS Drugs; 2015 Nov; 29(11):893-904. PubMed ID: 26507832 [Abstract] [Full Text] [Related]
3. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs. Brigo F, Bragazzi NL, Nardone R, Trinka E. Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868 [Abstract] [Full Text] [Related]
4. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center. Kurth C, Kockelmann E, Steinhoff BJ. Seizure; 2017 Feb; 45():47-51. PubMed ID: 27915111 [Abstract] [Full Text] [Related]
5. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. Runge U, Arnold S, Brandt C, Reinhardt F, Kühn F, Isensee K, Ramirez F, Dedeken P, Lauterbach T, Noack-Rink M, Mayer T. Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971 [Abstract] [Full Text] [Related]
6. Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy. Kim H, Faught E, Thurman DJ, Fishman J, Kalilani L. JAMA Neurol; 2019 Jul 01; 76(7):783-790. PubMed ID: 30933252 [Abstract] [Full Text] [Related]
7. Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: A US database analysis. Faught E, Helmers S, Thurman D, Kim H, Kalilani L. Epilepsy Behav; 2018 Aug 01; 85():37-44. PubMed ID: 29906700 [Abstract] [Full Text] [Related]
8. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project. Sirven JI, Shafer PO, Kalilani L, Wild I, Fishman J, Owens S. Epilepsy Behav; 2018 Mar 01; 80():98-103. PubMed ID: 29414565 [Abstract] [Full Text] [Related]
9. Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study. Kalilani L, Lu C, Pierre-Louis B, Gold M. Epilepsy Behav; 2017 Jul 01; 72():51-57. PubMed ID: 28575767 [Abstract] [Full Text] [Related]
10. The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: a systematic review and indirect comparison. Martyn-St James M, Glanville J, McCool R, Duffy S, Cooper J, Hugel P, Lane PW. Seizure; 2012 Nov 01; 21(9):665-78. PubMed ID: 22902288 [Abstract] [Full Text] [Related]
11. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Maschio M, Zarabla A, Maialetti A, Fabi A, Vidiri A, Villani V, Giannarelli D. Epilepsy Behav; 2017 Aug 01; 73():83-89. PubMed ID: 28623754 [Abstract] [Full Text] [Related]
12. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures. Steinhoff BJ, Eckhardt K, Doty P, De Backer M, Brunnert M, Schulze-Bonhage A. Epilepsy Behav; 2016 May 01; 58():35-43. PubMed ID: 27054272 [Abstract] [Full Text] [Related]
13. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy. Brigo F, Trinka E, Bragazzi NL, Nardone R, Milan A, Grillo E. Epilepsy Res; 2016 Nov 01; 127():12-18. PubMed ID: 27543806 [Abstract] [Full Text] [Related]
14. Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany. Nass RD, Kurth C, Kull A, Graf W, Kasper B, Hamer HM, Strzelczyk A, Elger CE, Steinhoff BJ, Surges R, Rosenow F. Epilepsy Behav; 2016 Mar 01; 56():54-8. PubMed ID: 26828693 [Abstract] [Full Text] [Related]
15. [Pharmacoeconomic aspects of monotherapy of focal epilepsy]. Mkrtchyan VR, Kaimovsky IL. Zh Nevrol Psikhiatr Im S S Korsakova; 2019 Mar 01; 119(11. Vyp. 2):92-98. PubMed ID: 32207738 [Abstract] [Full Text] [Related]
16. General Trends in Prices and Prescription Patterns of Anticonvulsants in Germany between 2000 and 2017: Analysis of National and Cohort-Based Data. Willems LM, Hamer HM, Knake S, Rosenow F, Reese JP, Strzelczyk A. Appl Health Econ Health Policy; 2019 Oct 01; 17(5):707-722. PubMed ID: 31161366 [Abstract] [Full Text] [Related]
18. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs. Neal A, D'Souza W, Hepworth G, Lawn N, Cook M, Nikpour A. Epilepsy Behav; 2018 Mar 01; 80():25-32. PubMed ID: 29396359 [Abstract] [Full Text] [Related]